As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000 people
have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all COVID-19-…

Bronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization
and infection. We present an approach to the multi-biome that integrates bacterial, viral …

Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …

Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …

Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Background The aim of this prospective, multicenter study was to define the accuracy of
lung ultrasound (LUS) in the diagnosis of community-acquired pneumonia (CAP). Methods …

Rationale: Eradication and suppression of Pseudomonas aeruginosa is a key priority in national
guidelines for bronchiectasis and is a major focus of drug development and clinical trials…

To understand how a protective immune response against SARS-CoV-2 develops over time,
we integrated phenotypic, transcriptional, and repertoire analyses on PBMCs from patients …

Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …